关于肠阿米巴病的研究进展

时间 : 2009-11-30 13:35:14 来源：www.yxsjy.net

栏目关注：溶组织内病因溶组织内症状溶组织内检查溶组织内怎么治疗溶组织内治疗方法

溶组织内饮食溶组织内用药溶组织内是什么病溶组织内自我治疗溶组织内早期症状

[摘要]

关键词：肠阿米巴病溶组织内阿米巴同工酶编码基因

　　肠阿米巴病是由溶组织内阿米巴（Entamoebahistolytica）引起的肠道传染病

　　一

　　Sargeaunt［1］分析比较了来自世界各地的6000多个溶组织内阿米巴分离株的同工酶谱

　　二

　　致病性溶组织内阿米巴滋养体膜上有特异性的30000

　　三

　　Clark等［9］证明了两群溶组织内阿米巴的核蛋白体基因（rDNA）

　　上述这些利用两群溶组织内阿米巴的酶

　　1．诊断：（1）从新鲜粪便中查到吞噬有红细胞的滋养体或从活检组织中查到滋养体是确诊肠阿米巴病最可靠的依据。（2）从粪便标本中仅查到

　　2．治疗：肠阿米巴病一经诊断，即患者确实被溶组织内阿米巴感染，

　　3．流行病

　　作者单位：100050北京热带医

　　1　SargeauntPG.ThereliabilityofEntamoebahistolyticazymodemesinclinicaldiagnosis.parasitologyToday,1987,3:40-43.

　　2　GathiramV,JacksonTF.FrequencydistributionofEntamoebahistolyticazymodemesinaruralSouthAfricanpopulation.Lancet,1985,1:719-721.

　　3　MirelmanD.EffectofcultureconditionsandbacterialassociatesonthezymodemesofEntamoebahistolytica.ParasitologyToday,1987,3:37-40.

　　4　SargeauntPG,BavejaUK,NandaR,etal.InfluenceofgeographicalfactorsinthedistributionofpathogeniczymodemesofEntamoebahistolytica:identificationofzymodemesⅪⅤinIndia.TransRSocTropMedHyg,1984,78:96-101.

　　5　BlakelyP,SargeauntPG,ReedSL.Aimmunogenic30-kDasurfaceantigenofpathogenicclinicalisolatesofEntamoebahistolytica.JInfectDis,1990,162:949-954.

　　6　QueX,ReedSL.TheroleofextracellulercysteineproteinasesinpathogenesisofEntamoebahistolyticainvasion.ParasitologyToday,1997,13:190-194.

　　7　PetriWAJr,JacksonTF,GathiramV,etal.PathogenicandnonpathogenicstrainsofEntamoebahistolyticacanbedifferentiatedbymonoclonalantibodiestothegalactose-specificadherencelectin.InfectImmun,1990,58:1802-1806.

　　8　LeippeM,BahrE,TannichE,etal.Comparisonofpore-formingpeptidesfrompathogenicandnonpathogenicEntamoebahistolytica.MolBiolParasitol,1993,59:101-110.

　　9　ClarkCG,DiamondLS.RibosomalRNAgenesof“pathogenic”and“nonpathogenic”Entamoebahistolyticaaredistinct.MolBiolParasitol,1991,49:297-302.

　　10　TachibanaH,IharaS,KobayashiS,etal.DifferencesingenomicDNAsequencebetweenpathogenicandnonpathogenicisolatesofEntamoebahistolyticaidentifiedbypolymerasechinreaction.JClinMicrobiol,1991,29:2234-2239.

　　11　EdmanU,MerazMA,RausserS,etal.Characterizationofanimmuno-dominantvariablesurfaceantigenfrompathogenicandnonpathogenicEntamoebahistolytica.jExpMed,1990,172:879-888.

　　12　DiamondLS,ClarkCG.AredescriptionofEntamoebahistolyticaschaudinn,1903（EmendedWalker,1911）separatingitfromEntamoebadisparbrumpt,1925.JEukaryotMicrobiol,1993,40:340-344.

　　13　WHO.Amoebiasis.WklyEpidemiolRec,1997,72:97-99.

　　14　HaqueR,NevilleLM,HahnP,etal.RapiddiagnosisofEntamoebainfectionbyusingEntamoebaandEntamoebahistolyticastoolantigendetectionkits.JClinMicrobiol,1995,33:2558-2561.

　　15　WalderichB,BurechardGD,KnoblochJ,etal.DevelopmentofmonoclonalantibodiesspecificallyrecognizingthecyststageofEntamoebahistolytica.AmjTropMedHyg,1998,59:347-351.

　　16　HaqueR,FaruqueAS,HahnP,etal.EntamoebahistolyticaandEntamoebadisparinfectioninchildreninBangladesh.JInfectDis,1997,175:734-736.

　　17　TachibanaH,TakekoshiM,ChengXJ,etal.BacterialexpressionofaneutralizingmousemonoclonalantibodyFabfragmenttoa150-kilodaltonsurfaceantigenofEntamoebahistolytica.AmJTropMedHyg,1999,60:35-40.

下载PDF文档

Tag：